Search Results

Displaying Results 226-250 of 314 "'SV'"

Nov 11, 2025, 08:37 ET Sailing For Veterans Announces Free Therapeutic Sailing Initiative For Veterans

Sailing For Veterans today announced a new program that honors veterans with free day sails on the sailboat SV INDRA located in Gloucester, MA. Launching on Veterans Day, in partnership with

More news about: Sailing For Veterans

Nov 11, 2025, 06:18 ET Zinzino AB (publ.): Zinzino acquires 35% of the shares in Andorra-based Xion International Group for further development of its own-produced omega-3 oil and spirulina

https://www.zinzino.com/site/se/sv-SE/om-oss/investerare/ For more information, please contact:

More news about: Zinzino

Nov 11, 2025, 06:15 ET Zinzino AB (publ.): Zinzino acquires 35% of the shares in Andorra-based Xion International Group for further development of its own-produced omega-3 oil and spirulina

https://www.zinzino.com/site/se/sv-SE/om-oss/investerare/ For more information, please contact:

More news about: Zinzino

Nov 09, 2025, 20:53 ET Sunseeker Robotics LiDAR Mower S4 utsedd till CES Innovation Awards® 2026 Honoree

content:https://www.prnewswire.com/sv/pressmeddelanden/sunseeker-robotics-lidar-mower-s4-utsedd-till-ces-innovation-awards-2026-honoree-302609622.html

More news about: Sunseeker Robotics

Nov 08, 2025, 10:15 ET AMGEN'S REPATHA® CUTS RISK OF FIRST MAJOR ADVERSE CARDIOVASCULAR EVENTS BY 25% IN LANDMARK PHASE 3 VESALIUS-CV TRIAL

Cardiovascular Disease. JACC, Volume 86 (Number 14) Shapiro MD. Circulation. 2022;146(15):1120-1122. Rao SV, O'Donoghue ML, Ruel M, et al. Circulation. 2025;151(13):e771-e862. Vasan, R. S., Enserro, D. M., Xanthakis, V., Beiser, A.

More news about: Amgen

Nov 07, 2025, 09:31 ET Dahua Technology inviger regionalt nav i Budapest och stärker det globala AIoT-ekosystemet och den lokala värdeskapandet

content:https://www.prnewswire.com/sv/pressmeddelanden/dahua-technology-inviger-regionalt-nav-i-budapest-och-starker-det-globala-aiot-ekosystemet-och-den-lokala-vardeskapandet-302608732.html

More news about: Dahua Technology

Nov 06, 2025, 17:07 ET DARZALEX FASPRO® is the first and only treatment approved by the U.S. FDA for patients with high-risk smoldering multiple myeloma

Primary Results of the AQUILA Study. Presented at the December 2024 ASH Annual Meeting & Exposition. Abstract JJD-78127.7 Rajkumar SV. Multiple Myeloma: 2020 Update on Diagnosis, Risk-Stratification and Management. Am J Hematol. 2020;95(5):548-5672020;95(5):548-567.

More news about: Johnson & Johnson

Nov 06, 2025, 08:04 ET Section Partners Raises $189 Million

venture-backed companies, through both primary and secondary transactions, alongside a dedicated equity co-investment fund, Section Ventures II, LP ("SV II"). The Firm serves as a trusted partner to late-stage, venture-backed companies by providing personal financing solutions to stockholders, purchasing

More news about: Section Partners

Nov 06, 2025, 08:00 ET Edgewise Therapeutics Reports Third Quarter 2025 Financial Results and Recent Business Highlights

extension period. In June 2025, the Company announced encouraging observations across functional measures, including Stride Velocity 95th Centile (SV95C), NSAA and 4 stair-climb, while identifying a dose of 10 mg to evaluate in Phase 3. FOX is designed to evaluate the effect of

More news about: Edgewise Therapeutics

Nov 06, 2025, 06:21 ET Scandic Trust Group stärker sitt försäljningsnätverk med First Idea Consultant

content:https://www.prnewswire.com/sv/pressmeddelanden/scandic-trust-group-starker-sitt-forsaljningsnatverk-med-first-idea-consultant-302607058.html

More news about: The HongKong Telegraph

Nov 05, 2025, 07:30 ET DeepL presenterar nästa generations AI-verktyg för språk och en banbrytande produktivitetslösning

content:https://www.prnewswire.com/sv/pressmeddelanden/deepl-presenterar-nasta-generations-ai-verktyg-for-sprak-och-en-banbrytande-produktivitetslosning-302604809.html

More news about: DeepL

Oct 31, 2025, 09:35 ET ZOE Energy Group påskyndar europeisk lokaliseringsstrategi med ny fabrik, uppgraderad affärsmodell och större orderteckningar under engagerande partnermöte

content:https://www.prnewswire.com/sv/pressmeddelanden/zoe-energy-group-paskyndar-europeisk-lokaliseringsstrategi-med-ny-fabrik-uppgraderad-affarsmodell-och-storre-orderteckningar-under-engagerande-partnermote-302601102.html

More news about: ZOE Energy Storage

Oct 31, 2025, 09:00 ET AMGEN'S LANDMARK PHASE 3 REPATHA DATA TO BE PRESENTED AS LATE BREAKER AT THE AMERICAN HEART ASSOCIATION SCIENTIFIC SESSIONS 2025

(investors) REFERENCES Rao SV, O'Donoghue ML, Ruel M, et al. Circulation. 2025;151(13):e771-e862. Vinci P, Di Girolamo FG, Panizon E, et al. Int J Environ

More news about: Amgen

Oct 31, 2025, 06:22 ET Weekly Recap: 13 Health Press Releases You Need to See

S&S Investment, SJ Investment Partners, Smilegate Investment, and Gauss Capital Management, as well as new investors Korea Investment Partners and SV Investment.

More news about: PR Newswire

Oct 30, 2025, 07:05 ET REGENXBIO Announces Completion of Pivotal Enrollment and Initiates Commercial Production in Duchenne Gene Therapy Program

4 years and older. Participants aged 1 to < 4 years will be evaluated using the Peabody Developmental Motor Scale-Third Edition (PDMS-3) and SV95C. In the Phase I/II portion of the trial, microdystrophin levels ranged from 20% to 122% in participants who received the pivotal

More news about: REGENXBIO Inc.

Oct 28, 2025, 19:00 ET Pinetree Therapeutics Raises $47 Million in Oversubscribed Series B to Advance Next-Generation Protein Degraders in Oncology

S&S Investment, SJ Investment Partners, Smilegate Investment, and Gauss Capital Management, as well as new investors Korea Investment Partners and SV Investment.

More news about: PineTree Therapeutics

Oct 24, 2025, 09:00 ET UtilityInnovation Group utökar sin nordamerikanska kapacitet genom strategiskt förvärv

content:https://www.prnewswire.com/sv/pressmeddelanden/utilityinnovation-group-utokar-sin-nordamerikanska-kapacitet-genom-strategiskt-forvarv-302593831.html

More news about: UtilityInnovation Group

Oct 24, 2025, 03:00 ET PolarBlue stärker sitt rådgivande team med Nino Ficca, banbrytande inom skalbar, utsläppsfri energi

content:https://www.prnewswire.com/sv/pressmeddelanden/polarblue-starker-sitt-radgivande-team-med-nino-ficca-banbrytande-inom-skalbar-utslappsfri-energi-302593389.html

More news about: PolarBlue

Oct 23, 2025, 12:32 ET VIRTUSA UTSER HARPREET ARORA TILL CHEF FÖR STORBRITANNIEN, EUROPA OCH MELLANÖSTERN

content:https://www.prnewswire.com/sv/pressmeddelanden/virtusa-utser-harpreet-arora-till-chef-for-storbritannien-europa-och-mellanostern-302593071.html

More news about: Virtusa Corporation

Oct 17, 2025, 14:30 ET Nabsys Presents Data Detailing OhmX™ Platform's Unique Advantages of Genome Mapping at American Society of Human Genetics (ASHG) 2025 Annual Meeting

research." "The presentations at the ASHG meeting further validate the OhmX Platform as an optimal solution for high-resolution SV analysis, and we were pleased to share the latest improvements and integrations of cutting-edge technology with the genomic research community," said

More news about: Nabsys

Oct 17, 2025, 09:30 ET Sage Care Emerges From Stealth with $20M in Funding for an AI-Powered Care Navigation System

Round led by Yosemite with support from General Catalyst, Chelsea Clinton, SV Angel, and others PALO ALTO, Calif., Oct.

More news about: Sage Care

Oct 16, 2025, 19:38 ET Ericsson och Export Development Canada stärker Kanadas ledarskap inom nästa generations nätverk med ett partnerskapsavtal på 3 miljarder USD

content:https://www.prnewswire.com/sv/pressmeddelanden/ericsson-och-export-development-canada-starker-kanadas-ledarskap-inom-nasta-generations-natverk-med-ett-partnerskapsavtal-pa-3-miljarder-usd-302587006.html

More news about: Ericsson

Oct 16, 2025, 14:30 ET Nabsys Presents Novel Disease Insights and Advantages in Structural Variant Detection using OhmX™ Platform at American Society of Human Genetics (ASHG) 2025 Annual Meeting

EGM offers streamlined analysis and scalable, cost-effective structural variant (SV) identification in hematological malignancies EGM enables efficient

More news about: Nabsys

Oct 16, 2025, 08:00 ET TECVAYLI® plus DARZALEX FASPRO® combination regimen significantly improves progression-free survival and overall survival versus standard of care

https://www.jnj.com/u-s-fda-approves-tecvayli-teclistamab-cqyv-the-first-bispecific-t-cell-engager-antibody-for-the-treatment-of-patients-with-relapsed-or-refractory-multiple-myeloma5 Rajkumar SV. Multiple myeloma: 2020 update on diagnosis, risk-stratification and management. Am J Hematol. 2020;95(5):548-5672020;95(5):548-567.